Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Insurance Based Investment Product Value for Money Methods

Abstract. Insurance-based investment products combine investment exposure, insurance contingencies, contractual guarantees, distribution services, and long-term liquidity conditions within one legal instrument. Value for money therefore concerns the relationship between the complete customer cost and the attainable benefit of a contract for its intended market across relevant economic, biometric, and behavioral states. This monograph examines how cash-flow valuation, reduction in yield, risk adjustment, contingent-benefit pricing, surrender analysis, and supervisory benchmarking contribute to that assessment. It distinguishes economic valuation from product governance and individual suitability, studies European and international regulatory approaches, and develops reproducible hypothetical calculations illustrating why a ranking based on annual fees or nominal returns alone can misrepresent consumer outcomes. The research combines primary regulatory documentation, official industry evidence, and selected peer-reviewed literature. The European analysis distinguishes the 2026 revised EIOPA benchmarking methodology from its historical predecessor and separates supervisory methodology from legislative developments. The analytical conclusion is that an evidence-supported judgment requires comparable exposures, explicit protection benefits, complete lifecycle charges, realistic holding behavior, and documented review of outcomes for the relevant customers. The calculations illustrate established methods; they are neither estimates of a particular market nor a new valuation theory.

Keywords: Insurance-based investment products; value for money; unit-linked insurance; hybrid insurance; reduction in yield; policyholder behavior; surrender value; actuarial valuation; product oversight and governance; distribution remuneration; consumer protection; supervisory benchmarking.

Introduction

The insurance-based investment product (IBIP) converts a premium into a contractually defined portfolio of future claims. The customer may receive an accumulated account value, a maturity benefit, a surrender payment, a death benefit, a guaranteed withdrawal stream, or an income contingent on survival. These contractual possibilities constitute a single economic position even when legal documentation describes them in separate sections. The economic problem of value for money (VfM) is to establish what the customer is required to pay, what benefit is attainable, the conditions governing its attainment, and the quality of the alternatives available to the intended customer.

The object of this study is hybrid investment and protection value. Annuity income adequacy, insurer portfolio performance, generic consumer fairness, and solvency regulation intersect with it but have their own research questions. The study concentrates on products in which investment outcomes and insurance contractual features jointly determine the wealth of the policyholder or beneficiaries. The EU is the central jurisdiction because IBIP is an EU legislative category; UK and US materials provide functional comparisons rather than legal equivalence.

The research asks how protection and investment value can be evaluated jointly, which metrics are comparable across contracts and regulatory settings, and how surrender costs, remuneration, and time change the assessment. The method is documentary comparative analysis combined with financial and actuarial calculations. Regulatory propositions are attributed to the instruments or supervisory documents that establish them. Academic findings are limited to the evidence available in the inspected publications or abstracts. All numerical examples created for this work use invented contracts and transparent assumptions. The study has no confidential policy-level data, rating files, or benchmark distributions and does not claim to validate the performance of an actual insurer.

The analysis uses three complementary perspectives: the customer's state-dependent benefits, the insurer's cost of providing those benefits, and the supervisor's assessment of product design and market conduct. Their units of analysis differ. A guarantee can be expensive to provide and nevertheless have little value to a customer who cannot use it. An investment product can be profitable for the insurer while supplying competitive consumer value. An exceptionally high investment return can arise from unusually high market risk without convincing evidence of superior design. These distinctions govern the interpretation of the following chapters.

Insurance-based investment product economics

Contract architecture and allocation of risk

An investment insurance contract usually comprises a contractual wrapper and one or more investment exposures. In a unit-linked contract, the account follows the value of designated units after deductions. The policy may give a customer a choice of investment options, but rights against the insurer, permitted withdrawals, beneficiary arrangements, exclusions, and guarantee obligations remain functions of the insurance contract. A profit-participating contract attributes returns according to an insurer's crediting or participation mechanism, subject to contractual floors, discretion and other conditions. Hybrid structures combine features with different forms of market participation or protection.

The distinctions matter because identical fund exposures can be delivered through different fees, guarantees, contractual rights, and servicing arrangements. Conversely, an apparently identical guaranteed floor can be accompanied by different investment restrictions or exit terms. A fair comparison identifies the investment strategy, currency, contribution pattern, risk-bearing party, accessible account value, insured event, timing of guarantees, and treatment on termination.

The allocation of risk takes place through contractual cash flows. Market risk may affect the account value directly. Biometric risk may be borne partly by an insurer through a benefit that exceeds the investment account. Duration, liquidity, and counterparty exposure affect the possibility of converting a legal right into usable cash. An insurer may hedge market guarantees or retain residual exposure. The customer may bear losses from a withdrawal undertaken before a guarantee date. Protection of a particular terminal value cannot automatically be interpreted as protection of the customer's consumption needs at every intervening date.

In the United States, the SEC's description of variable annuity contract features (n.d.) illustrates the joint presence of investment options, death benefits, optional living benefits, and annuitization. These economic functions are comparable with certain European products while the legal category, tax consequences, and distribution obligations differ.

Value, price, and alternative opportunities

The financial value of a contract can be assessed through discounted cash flows. Define P_t as premium paid at time t, W_t as withdrawals, B_t as event-contingent payments, and F_t as separately paid customer fees. A simplified net customer cash flow is X_t = W_t + B_t - P_t - F_t. Benefits paid to beneficiaries belong in the household-level analysis when their welfare is within the stated objective. Charges already deducted from the account are reflected in W_t and B_t and must not be subtracted a second time.

For a fixed discount sequence d_t, the present value of a scenario is the sum of d_t X_t across time. Its probability-weighted mean gives one measure of economic outcomes. This measure is meaningful only after the probability model, discount assumptions, timing, and perspective have been stated. In market-consistent guarantee valuation, market prices or a calibrated risk-neutral model determine the financial hedgeable components; in consumer planning, real-world scenarios are used to represent possible lived outcomes. The distinction is consequential: an expectation under a pricing measure is not a predicted household return.

A comparison set should include realistic products available to the relevant group. Possible alternatives include a different investment insurance wrapper with similar exposure and cover, an investment account combined with independently obtainable insurance, or a lower-risk savings arrangement when that matches the objective. A standalone fund without insurance is a useful diagnostic for investment costs; it becomes a complete counterfactual only after differences in cover, tax, accessibility, service, and other rights have been reconciled.

An economically efficient product turns customer payments into benefits at a competitive cost while respecting the customer's constraints. The relevance of a particular benefit is heterogeneous. A death benefit can be valuable to a household with financially dependent beneficiaries, a lifetime guarantee can matter to someone with longevity exposure, and contractual flexibility can protect a worker with volatile earnings. A costly rider that provides an objectively real financial option may still fail to benefit much of the intended segment if the event covered is mismatched to its needs.

Pricing and welfare perspectives

Product profitability compares income attributable to the product with claims, administration, acquisition, asset management, capital, and hedging costs. The customer's valuation compares the combined outcomes with payments and alternative opportunities. The two calculations share cash-flow information, but they answer different questions. A cost allocation policy can produce positive insurer margins without demonstrating that the consumer's price is justified. Equally, an insurer subsidizing a guarantee may deliver financial value without establishing suitability for every purchaser.

A standard expected-utility representation can make the distinction concrete. For final wealth W and increasing concave utility u, the certainty equivalent CE solves u(CE) = E[u(W)]. A risky contract with a higher mean terminal payoff can have a lower certainty equivalent than a less risky contract. The result depends on wealth, risk aversion, other assets and liabilities, and the timing of consumption. A policyholder group is therefore not characterized by a single universally valid utility coefficient. When utility assumptions are too weakly supported, reporting the distribution of losses, liquidity breaches, and downside scenarios gives a more transparent assessment than assigning precise welfare estimates.

The comparison must also account for the time distribution of costs. Two contracts yielding the same maturity amount can have different surrender trajectories, and two guarantees with the same advertised amount can protect different periods. What is economically purchased is a schedule of contingent rights, not simply a terminal advertised return.

Total-cost and fee structures

Complete lifecycle cost inventory

Customer payments can be allocated among entry charges, recurring contract charges, management and transaction costs of underlying investments, protection charges, advisory fees, and exit charges. A fixed administration charge and a percentage deduction from assets have different effects at different premium sizes. A percentage fee can be charged against account value, contribution value, guaranteed benefit base, or another contractual denominator. A payment made by an asset manager to the distributor may be financed from a fund charge already present in the customer's account; recording the remuneration separately for conduct analysis does not create an additional cash outflow.

The cost inventory distinguishes the economic incidence of a charge from the recipient of the transfer. The customer cares about the total amount paid or deducted. The manufacturer needs to know who receives revenue, what service is provided, and how the charge affects different customer groups. A complete ledger reconciles both perspectives to the contract cash flows and discloses uncertain or unavailable third-party amounts.

Article 29 of the Insurance Distribution Directive (European Parliament and Council, 2016) requires relevant IBIP cost information, including distribution and advice where applicable, in aggregate form showing the cumulative effect on return, with itemization on request. This gives disclosure a lifecycle significance in addition to the price quoted at sale. The statutory disclosure categories and the internal economic inventory should be reconciled rather than presumed identical.

An actuarial ledger should attach each cost to its charge base, frequency, timing, payer, recipient, and triggering conditions. It should identify embedded layers, rate changes by policy duration, discounts, bonuses subject to clawback, and separately paid advice. An investment fee included in a fund's net asset value is not deducted again from a return series already net of that fee. Tax is reported in a separate scenario layer so that contractual costs and fiscal effects remain distinguishable.

Accumulation and reduction in yield

For a single-premium contract with beginning premium P, entry charge proportion e, gross annual return g and end-of-year proportional charge c, an illustrative account without withdrawals is A_t = P(1-e)[(1+g)(1-c)]^t. Actual contracts may have monthly deductions, fixed charges, contributions, protection charges dependent on net amount at risk, bonuses, or nonlinear crediting. Their actual timing and contractual equations must replace the simplified expression.

A gross annual yield is the annualized growth rate before the specified costs; a net yield reflects the same cash-flow scenario after those costs. The difference, measured in percentage points per year, is a form of reduction in yield (RIY). For a single cash flow at maturity, the annual net yield is (A_T/P)^(1/T)-1. In more complex cash-flow schedules the internal rate of return (IRR) solves the conventional discounted cash-flow equation for the yield r that makes net present value zero. Multiple sign changes may produce multiple IRRs or no economically interpretable root; in such cases net present value or a disclosed reinvestment convention is preferable.

In the EU standardized disclosure context, the PRIIPs regulatory technical standards (European Commission, 2017, consolidated 2023) specify cost methodology and annual yield-reduction indicators. The simplified example below demonstrates compounding and does not reproduce the regulation's complete scenario, risk-premium, or cost-calculation rules.

Annex VI, points 59–60 of the same delegated regulation distinguish the cost component of biometric risk premiums from their fair value and permit the specified alternative treatment of the full premium. Points 70–74 establish annualized yield reduction under prescribed calculations, including the assumption of no insurance coverage payments during the holding period. The standardized cost indicator and an actuarial valuation of actual contingent protection consequently answer different questions.

Worked accumulation comparison

Consider two hypothetical investments with the same initial payment of 10,000 currency units, no additional contributions, no taxes, no withdrawals, and constant gross return of 5% per year. Contract A deducts 3% on entry and 2% of account value at each year end; B has no entry charge and charges 0.5% at each year end. These amounts are invented for exposition. There is no surrender charge in this first calculation.

Holding period Gross no-cost terminal value Contract A Contract B
1 year 10500.00 9981.30 10447.50
5 years 12762.82 11190.48 12446.92
10 years 16288.95 12909.98 15492.58
20 years 26532.98 17182.22 24002.01

At ten years, the annualized net yield of A is 2.59%, and that of B is 4.48%. Against a 5% gross yield, the simplified annualized cost impacts are 2.41 and 0.52 percentage points, respectively. The ten-year terminal difference is 2582.60 currency units in favor of B under the stipulated assumptions.

The difference is not equal to the nominal sum of charges. Costs remove capital that otherwise compounds. The table therefore depicts total wealth forgone relative to the stated scenario, not an accounting statement of cash charges received by the provider. Comparing sums of contractual charges and opportunity-cost effects is valuable, but each measure needs an explicit definition.

Scale and duration effects

Suppose an annual fixed fee is 60 currency units. On an account of 1,000 it represents 6% of opening balance, while on an account of 100,000 it represents 0.06%. Both customers receive the same monetary deduction, but the incidence relative to their available wealth differs sharply. A product apparently competitive in an average-premium analysis can impose high effective charges on low-balance customers. Regulatory assessments should therefore not depend only on premium-weighted averages.

Entry charges decline in annualized importance as the holding period lengthens, while recurring charges accumulate across years. This produces cost-profile crossings: a low-entry/high-annual-fee contract can be less expensive early and more expensive late than a high-entry/low-annual-fee contract. Surrender penalties add a third time-dependent component. A single RIY reported at the recommended holding period cannot reveal all these crossings. Reporting several durations, contribution bands, and exit states allows the assessor to identify who bears high costs and when.

The economic benefit of advice must be assessed against the entire compensation schedule and the service actually supplied. A substantial initial payment could fund work that improves a consumer's decision, but its structure can also favor products with profitable acquisition for the distributor. Deferred remuneration changes incentives over time and may support retention or ongoing service, yet its presence alone does not establish service quality. Compensation accounting and customer-benefit assessment remain linked tasks.

Protection and investment scenario modeling

Insurance benefit and incremental protection

A valuation of an insurance feature starts with the contingent payoff added to the underlying investment. For a guaranteed minimum death benefit, let A_t be the amount payable from the investment account and G_t be the contractual death floor. The insurer's incremental top-up on an eligible death is max(G_t-A_t,0). Counting G_t and A_t as two independent payments would overstate the value whenever the benefit is the larger of the two.

A stylized actuarial present value for the incremental top-up is the sum over periods of d_t E[I_t max(G_t-A_t,0)], where I_t indicates an eligible death during the period while the policy remains in force. In an independent one-period illustration with fixed conditional death probability q, the probability-weighted top-up is q E[max(G-A,0)]. Real models may require age, underwriting, joint variation of lapse and financial conditions, disability or longevity assumptions, and timing of premium and benefit settlement. Counterparty and claims eligibility also matter to the attainable customer benefit.

Bauer, Kling, and Russ (2008) examine guaranteed minimum benefit valuation with specified and optimized withdrawal and surrender behavior in a risk-neutral framework. The inspected abstract supports the importance of policyholder options in pricing, not a universal estimate of what all guarantees cost. Market-consistent values are conditional on contract design and the financial model. They provide a check on the plausibility of protection charges, while actual consumer value also depends on whether the insured event and the protection horizon meet household needs.

An illustrative death-benefit valuation

Assume that at a designated one-year event date the investment account is 7,000 with probability 0.3 and 12,000 with probability 0.7. An eligible death triggers a minimum benefit of 10,000, otherwise the account is payable on death. Death probability is 0.01 and is stipulated independent of the investment state. The top-up in the low state is 3,000, and in the high state it is zero. The expected incremental payout is 0.01 × 0.3 × 3,000 = 9 currency units; its present value at 3% is 8.74.

The 10,000 floor is not itself an incremental benefit of 10,000. The guarantee can nevertheless have value greater than expected payout to a risk-averse household exposed to the insured contingency. A fair premium assessment may include administration, risk-bearing and capital costs, contractual options, dependence and distribution costs. These elements cannot be inferred from the one-period illustration, and the number 8.74 is not a quoted market premium or fair-price conclusion.

A guarantee effective only at a maturity date has a different payoff. In that case, for an eligible surviving policyholder, the increment is max(G_T-A_T,0). If an early withdrawal extinguishes the option, valuation must incorporate the probability and consequences of exercise or forfeiture. An income guarantee may depend on a notional benefit base that is not a withdrawable account balance. Separating the benefit base from account value prevents overstating cash accessible to the consumer.

Scenario analysis and risk adjustment

A useful investment scenario set spans adverse and favorable price paths, different inflation levels and interest rates, correlated shocks, and alternative withdrawal dates. It distinguishes nominal monetary amounts from real purchasing power. A gross nominal return of 5% with inflation of 4% corresponds to a real return of approximately 0.96%, calculated as 1.05/1.04-1. A nominal guarantee of initial premium at maturity could thus coincide with a substantial real loss over long periods.

A scenario should disclose the source of returns, calibration window, statistical treatment of fees, and whether the result is a conditional deterministic path or a simulated outcome distribution. Volatility, serial dependence, correlations and extreme outcomes have different implications for nonlinear guarantees. A historical-return reconstruction illustrates exposure under past conditions, while a forward scenario addresses a conditional future possibility. Neither automatically constitutes a probability forecast.

Expected return and standard deviation are useful first summaries when distributions are sufficiently regular, but variable insurance payoffs often display asymmetry, floors, caps or path dependence. Report the probability of a loss relative to contributions, a relevant real wealth shortfall, and loss severity conditional on adverse states. Quantile loss measures require a clear sign convention and horizon. Expected shortfall should identify the worst tail being averaged and avoid confusing percentiles of returns with percentiles of loss. Where reliable probabilities are absent, transparent stress outcomes are more defensible than precise tail probabilities.

Sequence of returns and rider conditions

Consider an account of 100 before two annual withdrawals of 10, with no fees. If the annual returns are +20% then -20%, the account becomes 110 after the first withdrawal and 78 after the second. Reversing the returns yields 70 after the first withdrawal and 74 after the second. Both scenarios share the same cumulative gross investment multiplier of 0.96 before withdrawals. Cash-flow timing produces different available wealth and could affect a guarantee trigger.

A guarantee that limits losses after adverse market movements changes the distribution of future payments. The value of that protection depends on withdrawal rules, benefit-base recalculation, asset restrictions, guaranteed rate and insurer performance. A model that assumes fixed behavior can be an adequate sensitivity case, whereas a model allowing economically optimal choices can reveal option cost under a different behavioral assumption. Observed behavior may depart from both due to advice, liquidity shocks, inertia, limited knowledge, or contract complexity.

Comparing insured and unbundled alternatives

Return to hypothetical contracts A and B. A may include a genuine guarantee that B lacks. The terminal wealth difference computed above identifies the financial hurdle that the extra contract rights would need to overcome under that path, conditional on equivalent other services. It cannot establish the guarantee's value on a path where the guarantee is valuable precisely because market returns are low.

A more informative calculation matches the actual insured contingent cash flows with an obtainable replacement product and compares total net costs over the relevant periods. An analyst should verify eligibility, underwriting, premium rates over time, beneficiary conditions, portability and lapse risk for separate insurance. If the independent cover cannot be bought by the target group, a hypothetical cheap replacement is not a feasible alternative. In such cases direct comparison of scenario-dependent outcomes and documented protection needs is more reliable than a mechanical additive cost comparison.

Suitability, surrender and liquidity constraints

Time horizon and accessible value

The account value A_t is not necessarily the amount that can be obtained at time t. Define a simplified surrender payment S_t = A_t(1-s_t) - k_t, where s_t is a percentage exit deduction on the stipulated base and k_t is a fixed amount. Actual contracts may use contribution bases, market-value adjustments or separate benefit reductions. The account-to-surrender reconciliation must therefore be specific to the policy wording.

Consider contract A from the earlier example. Impose a hypothetical 5% surrender charge on account value after one year and 2% after five years, zero at ten years. The year-one surrender payment is 9482.23 and the year-five payment is 10966.67. Compared with the original premium, the year-one surrender payment yields -5.18% and the year-five annualized yield is 1.86%. The charge changes the accessible outcome even though the underlying investment earns the same assumed 5% each year. Any guarantee lost on surrender creates an additional contractual consequence beyond the immediate cash deduction.

Early surrender is neither uniformly irrational nor proof of mis-selling. A household can experience unemployment, medical expenses, migration or changed family obligations. An early-exit pattern is nevertheless informative when combined with recorded reasons, product eligibility, marketing descriptions, adviser recommendations, and losses at exit. A specified holding period is an analytical input, not evidence that actual households possess liquidity for that duration.

Where detailed data exist, a cohort analysis should define the initial exposure and distinguish partial withdrawal, full surrender, death, maturity, transfers, lapse and administrative cancellation. Rates measured per policy count and per premium volume answer different questions. Survival analysis and competing-risk techniques can address right censoring and mutually exclusive termination causes. The observed number of surrenders must be related to the number exposed and the period at risk. A mature closed block cannot be compared directly with a recently sold cohort without accounting for duration.

Suitability and target market

Under Article 30 of the IDD suitability rules (European Parliament and Council, 2016), advised IBIP sales require relevant knowledge, experience, financial circumstances, loss-bearing capacity, objectives and risk tolerance. Non-advised appropriateness is a distinct assessment, subject to the Directive's conditional derogation and national implementation. Product-level testing examines the needs of a defined target market; individualized assessment examines whether the recommendation or relevant sale process is appropriate to the particular customer.

A favorable product-level cost assessment does not resolve a mismatch between investment duration and customer need. Conversely, a customer may have an objectively important need for a benefit provided by a higher-cost contract. A target market should specify relevant loss tolerance, premium size, knowledge, income and liquidity characteristics, purpose of the protection, insurance eligibility and distribution channel. Segmentation should be sufficiently granular to identify harmful variations while still supported by meaningful observations.

Suitability review must distinguish the customer's existing portfolio from the standalone contract. A guaranteed income product could reduce household longevity risk even if it has lower expected investment growth than equities. The same product could increase liquidity concentration if most accessible savings are committed to it. A product's investment risk measure does not capture all consequences of household-level concentration, liquidity, or contract eligibility.

The relevance of non-financial service should also be evidenced. Clear information, reliable access, assisted distribution, understandable policy changes, and accurate execution may improve use of a contract's benefits. The assessor should avoid treating marketing features as benefit equivalents without showing their function, availability, and actual or credibly expected use by customers.

Governance of value-for-money decisions

Design responsibility and evidence

The manufacturer owns the economic design and product approval process. Distribution partners have information on sale patterns, customer objectives, compensation and service. An evidence-based assessment draws on both. Single-source data from an insurer's actuarial department may omit actual third-party fees; a distributor's transaction record may omit embedded protection charges. The cost and outcome perimeter must be established jointly, with responsibilities matching the applicable law and business arrangements.

The EU product governance delegated regulation (European Commission, 2017, Articles 6–7) provides requirements for initial testing, relevant scenario analysis, recurring review, and monitoring of fit with the target market. Product approval is therefore a continuing assessment of design and distribution. A signed document without underlying scenario assumptions, relevant data and a review mechanism has little evidentiary value.

An assessment file should establish a product identifier and version, applicable jurisdiction and legal date, target-market definition, contractual features, complete cost perimeter, comparator selection, scenario assumptions, results by relevant group, distribution remuneration, known data limitations, decisions and remedial actions. Closed or legacy versions should remain traceable. Changes in fee tables or guarantee rules require the affected cohorts to be distinguished rather than aggregated into a generic product average.

Validation should begin with reconstruction of cash flows from policy terms and representative transaction records. Independently reproduce a sample of customer account values, fee deductions, surrender settlements and insured payouts. Theoretical calculations should be tested against known limiting cases: zero fees, no guaranteed shortfall, zero probability of the insured event, and termination before the guarantee becomes exercisable. These checks find double counting, timing mistakes and incorrect denominators before outputs are used in governance.

Distribution remuneration and conflicts

Economic governance of remuneration requires more than comparing the total commission with a predetermined percentage. The assessor identifies the source of remuneration, the behavior incentivized, the service provided, and its relationship to consumer harm. A sales-volume incentive can influence distribution even when displayed annual charges are similar across products. Replacement incentives may create repeated entry costs or restart surrender restrictions.

Egan, Ge, and Tang's (2022) variable annuity distribution study reports that more expensive annuities tend to pay brokers higher commissions, and that sales of high-expense products fell 52% after a 2016 US fiduciary-rule proposal. This is evidence from a particular market and regulatory episode; the inspected abstract does not establish a general causal coefficient for every distribution regime. Its relevance here is that compensation structures can be studied through actual product selection and outcomes rather than treated exclusively as internal accounting arrangements.

The product committee should examine high-remuneration sales by cohort, product switching, repeated surrender and repurchase, distribution channel, service delivery and differences in product selection at comparable customer needs. Statistical associations call for investigation rather than automatic findings of misconduct. A shift in product mix may arise from changed market conditions, customer demand or availability of different benefits. A credible inquiry states alternative explanations and tests those for which it has data.

Monitoring outcomes and remediation

Outcome monitoring connects prospective analysis to actual experience. Useful observations include net realized returns by entry cohort, charges paid, surrender losses, claims eligibility and acceptance, unusable riders, complaints, service availability, and sales outside the documented target market. The outcomes should be linked to exact product versions and bases of measurement. A low claims frequency on a rare-event protection rider is expected; low realization of promised services due to exclusion, misunderstanding or operational failure calls for different investigation.

Any comparison of mean returns must distinguish contribution-weighted investor outcomes, asset-weighted product performance, policy-weighted outcomes and returns per investment option. When multiple investment options are attached to one wrapper, treating every option as an independent product can distort the product count and overrepresent manufacturers with large menus. Distribution analysis requires consistent definitions of wrapper, option, contract, and premium volume.

Evidence of serious divergence should lead to an explicit decision: further analysis, modification of fee or feature design, limitation of the target market or distribution, improved service, suspension of new sales, or examination of appropriate remediation for existing customers. The decision should identify responsibility, underlying evidence, implementation and retest criteria. Any individual redress is governed by applicable law and facts and cannot be derived from a generic RIY threshold.

Supervisory benchmarks and internal decisions

European supervisory work has developed from EIOPA's 2021 supervisory statement on value and its 2022 unit-linked assessment methodology. The former establishes the role of value in product governance; the latter describes a common basis for national competent authorities with flexibility for local evidence. Such work differentiates market-wide risk screening from deeper product-specific investigation.

The 2026 updated methodology is examined in the comparative chapter below. For an internal manufacturer, a peer comparison can expose unfavorable costs or returns, but the assessment must still ask what features the customer actually receives. A peer group containing only expensive products does not establish that its typical product delivers acceptable value. A low-cost outlier may supply inadequate coverage or servicing. A product can warrant further attention through nonprice outcomes even when all cost indicators appear ordinary.

European and international comparative evidence

European benchmarking in 2026

On July 6, 2026, EIOPA released its revised benchmark methodology (EIOPA, 2026), replacing the 2024 version. The methodology is a risk-based supervisory instrument. It differentiates comparable contracts by product features, combines several cost and return measures, and requires further assessment of identified risks. The published approach is distinct from access to the actual supervisory benchmark values, which this study does not possess.

For the indicators in section 3.2, the unit of observation and denominator are critical. The methodology considers entry costs relative to total premiums, total costs relative to total premiums, RIY, surrender proceeds relative to cumulative premiums, and investment-option IRR. The wrapper and investment are generally considered together except for the investment-option IRR. The methodology uses holding-period-specific observations; for eligible longer contracts it additionally includes a midpoint comparison. These measures capture different aspects of the cost and benefit relationship.

Peer clusters depend on relevant features including premium frequency, duration, biometric cover and investment characteristics. Hybrid product construction affects whether components or predetermined combined exposures are assessed. The goal is a sufficient number of economically comparable products, not arbitrary similarity across brand labels. Sparse groups and differences in host markets require care.

Section 3.3 sets the unfavorable directions of the quartile benchmarks: upper quartiles for cost measures and lower quartiles for surrender and return measures. The caution band uses within-interquartile dispersion. These rules identify relative positions and aid prioritization. They are not a universal fee cap or a finding of unfairness without additional evidence. Non-clustering features, guarantees, protection claims, early exits, and other contextual information can alter the interpretation. The published document itself does not supply the confidential product-level thresholds used by individual supervisors.

An analyst replicating the statistical technique on its own peer sample should disclose sample size, grouping, quantile estimator, missing observations, treatment of duplicates, and measurement dates. Quartiles can be unstable in small groups. Comparing several indicators creates correlated warning signals: high total costs and RIY may reflect the same underlying charges. A dashboard must distinguish corroboration from redundant measurements. Where the benchmark distribution is endogenous to a market with persistently high charges, external alternatives and direct customer outcomes provide a useful second test.

Reading the recent EU evidence

EIOPA's 2026 costs and performance report covers 2020 through 2024 with standardized insurer submissions and includes only products present on the market at the end of 2024. Its official report findings (EIOPA, 2026) describe a sample of almost 6,000 insurance products from 175 undertakings. Average annual nominal returns over the reported interval were 1.5% for profit-participation products, 2.2% for lower-to-medium-risk unit-linked products, and about 8% for higher-risk unit-linked products.

These are documented descriptive findings, not expected future returns or causal estimates of the effects of charges or guarantees. Market exposures differ, and the ending-market availability condition creates a potential selection boundary. The correct comparison must consider risk and objective, and the contract-level distribution may differ from reported averages. The present study has not re-estimated the survey statistics or examined individual insurer submissions.

The Retail Investment Strategy illustrates the importance of keeping legislative change separate from supervisory practice. The European Parliament's retail investor legislative file (2026) records a vote on November 12, 2026 and lists the parliamentary first-reading procedure. The proposed amendments are therefore not treated as enacted obligations in this analysis. Subsequent procedural developments would require separate verification. The pre-existing IDD and POG provisions and the published EIOPA supervisory approach remain the basis of the methods described here.

United Kingdom

The FCA's Consumer Duty addresses consumer outcomes through the relation of customer price to benefits. Its fair value framework review (2023, updated 2025) describes the importance of considering product benefits, limitations, lifetime price, and the respective roles of manufacturers and distributors. The review examined fourteen frameworks in a nonrepresentative sample and did not individually assess the underlying products. It helps identify governance expectations and practical evidence questions rather than demonstrating the prevalence of poor value throughout the insurance industry.

The UK concept can be applied methodologically to products combining financial and insurance features by mapping services, risks, restrictions, and total costs. Relevant Handbook perimeter and specific investment insurance provisions must be checked for each product. Rules written specifically for non-investment insurance should not be imported indiscriminately into IBIPs. The comparative value of the UK example lies in the explicit customer-outcome focus and the assessment of the relationship between price and attainable benefit.

A quantitative assessment may combine outcome distributions with service and protection quality. Quantifying the financial components is useful; forcing a monetary value on every intangible benefit can create false precision. A written judgment can establish why each benefit is important, what evidence supports its availability, and whether its significance is sufficient to explain price differences.

United States and cross-jurisdiction comparability

The US market provides functional parallels through variable annuities and certain investment-linked life products. The SEC's variable annuity investor guidance describes fee, surrender, protection and investment characteristics. Applicable oversight may involve state insurance law and federal securities regulation. Tax treatment, product terminology, guarantee conditions, and sales channels differ from Europe.

The NAIC's annuity best interest standard (n.d.) explains the 2020 revision of Model Regulation 275 and its recommendation standard emphasizing consumer interest. A model regulation is a basis for state adoption and should not be described as directly binding national law. Its implementation must be verified by state. The functional comparison concerns suitability, remuneration conflicts and product understanding; the study does not infer that every US contract is subject to the same requirements as an EU IBIP.

Assessment dimension European Union United Kingdom United States
Core comparison focus in reviewed material Product governance and comparable-product VfM risk Customer price relative to anticipated benefits Recommendation and product features, costs and conflicts
Main evidence examined here IDD, POG, PRIIPs methodology and EIOPA documents FCA fair-value supervisory review NAIC model explanation and SEC guidance, plus academic annuity research
Applicability boundary EU instruments and national implementation Product and firm perimeter under applicable FCA rules State-specific adoption and applicable securities oversight
Transferable method Lifetime cost and risk-adjusted outcomes Explicit benefit and limitation review Remuneration, surrender, protection and suitability analysis

International comparison becomes credible when product features and customer outcomes are aligned before translating regulatory concepts. Real returns, net cash flows, and benefit eligibility can often be reconstructed across jurisdictions. A regulatory RIY calculated under one set of assumptions is not automatically comparable with an expense ratio in another. Tax differences should be shown under consistent assumptions or isolated from the common pre-tax results. The objective is commensurable economic evidence and clear local legal meaning.

Integrated assessment and methodological limitations

Reproducible application to a hypothetical contract

An assessment begins by choosing the object: the wrapper version plus relevant investment option and riders for a given customer segment. Record premium timing, fee schedules, death or maturity benefits, guarantees, withdrawal rights, eligibility and exclusions. Construct a cash-flow engine for these terms, including correct treatment of cash holdings and state-contingent payments. Run the same engine under base, stress and alternative behavior assumptions.

For a numerical sensitivity exercise, use contract A and B with the parameters previously given. Define three deterministic gross returns, -2%, 5% and 9%, held constant for ten years. Assume no surrender charges, no protection increments, no taxes and no withdrawals.

Gross annual return A ten-year account B ten-year account B minus A
-2% 6475.80 7771.26 1295.46
5% 12909.98 15492.58 2582.60
9% 18762.79 22516.24 3753.44

B has a higher account in every stated path because it has both a lower initial and a lower ongoing deduction and the same gross exposure. This is a conditional dominance result on account wealth, not on complete insurance welfare. If A additionally guarantees a maturity amount of 10,000, available only to an eligible continuing policyholder, A's low-return maturity payment would become 10,000 rather than its lower account balance. B pays precisely its own account value of 7771.26 in that scenario. A exceeds B in the low-return state; B's account advantage in the base and high states persists because the guarantee does not bind. The contract must now be compared on net cost, contingent outcomes, protection need, liquidity and probabilities. The guarantee is a hypothetical extra feature, and no guarantee fee beyond the stipulated charge is assumed.

This example exposes why the comparison should be performed across states rather than by treating a guarantee as a fixed monetary add-on. Risk-averse preferences may assign extra significance to the state in which the guarantee binds. A customer likely to surrender before maturity may assign substantial weight to the interim accessible outcomes instead. The assessment of the intended group determines the importance of these two observations.

Robustness and interpretation

A rigorous analysis tests results against alternative return assumptions, fees, discount rates, inflation, lapse patterns and insured-event probabilities. Where mortality and lapse data are available, those assumptions should be aligned with observed experience and independently challenged. Where contractual policyholders can choose investment options or withdrawals, the assessor should identify whether behavior is assumed fixed, stochastic, experience-based, or economically optimized. Results that rely on an unusually favorable behavior assumption should be identified as conditional.

For a sensitivity analysis, vary one assumption at a time to understand directional effects; vary interacting inputs jointly when dependence is economically relevant. A market decline can coincide with heightened liquidity pressure and more early withdrawals. Assuming independent shocks could materially overstate the availability of maturity guarantees. Conversely, assigning universal immediate surrender in adverse markets could mechanically understate protection. The assumptions are empirical questions rather than mathematical conveniences.

The appropriate output is a documented set of results, each with a clear unit, time horizon and limitation. A normalized cost ratio, a tail-risk metric, a guarantee payout distribution, a surrender trajectory, a suitability finding and a service-quality observation offer distinct information. Collapsing them into a single weighted score would require defensible trade-off weights and evidence that the score preserves economically material distinctions. Without that evidence, separate indicators and written interpretation are preferable.

The evidentiary burden of a product claiming to justify higher cost with superior protection consists of demonstrating the contractual difference, its relevance to the segment, its operation under stressed conditions, its accessibility over actual holding periods and the magnitude of the price difference. The claim should be revisited when underlying risks, charges, or customer behavior materially change. Relative benchmarks can prioritize this work; cost and benefit reconstruction supplies the substantive foundation.

Scope of the research and limits of inference

The study is an analytical and documentary investigation with selected primary legal and supervisory material. It does not produce market estimates from raw datasets. The two named actuarial and finance studies were checked through published abstracts and bibliographic records; detailed econometric specifications, calibrations, confidence intervals, appendices and replications are outside the evidence read. Their use is restricted to the findings stated in the abstracts. The relevant Annex VI provisions were checked in the extracted text of the consolidated January 2023 document; visual PDF retrieval was unavailable, and the simplified computations are not regulatory templates. The 2026 benchmark document was inspected in relevant sections, and public threshold values are not inferred. National EU transposition, UK product-perimeter rules and US state law would require separate jurisdiction-specific examination before any compliance decision.

The comparative and numerical material supports methodological conclusions, not determinations about named insurers, individual customers or market-wide value levels. No new theoretical system or novelty claim is advanced. A more comprehensive empirical extension would require contract-level charges, guarantee specifications, customer cohorts, distribution remuneration, surrender records, competing termination causes, actual services and appropriate comparator data, together with permissions and validation. That work would test whether the documented risks and trade-offs are important in a particular population.

Conclusion

The value for money of an insurance-based investment product arises from its complete contract economics under the conditions relevant to the intended customer. Investment performance, explicit and implicit fees, biometric benefits, guarantees, surrender, service and distribution terms together determine the accessible outcome. The methodological task is to reconstruct these components consistently and compare them against feasible alternatives.

Reduction in yield expresses compounded cost effects under stated cash-flow assumptions. It cannot independently establish protection value. Actuarial and financial option valuation identifies contingent benefit costs, but does not by itself establish suitability or service quality. Surrender analysis reveals the discrepancy between recommended holding periods and accessible wealth, while cohort-level outcome analysis connects prospective product testing to actual experience. Each method has a distinct role and limitation.

The comparative evidence establishes the practical importance of regulatory context. EIOPA's revised 2026 methodology prioritizes supervisory scrutiny through comparable-product indicators and judgment. The FCA's documented review emphasizes the relationship between total customer price and benefit. US annuity materials and distribution research demonstrate the relevance of recommendation quality, expenses, guarantees and conflicting incentives. The shared economic questions remain transferable across jurisdictions only when contract definitions, legal scope, risk, duration and tax assumptions are aligned.

The original analytical synthesis of this monograph is the explicit reconciliation of customer cash flows with incremental insurance protection and attainable exit value. The hypothetical calculations show that a lower-cost contract dominates on account wealth when other features match, while a state-contingent guarantee may reverse the ranking under adverse states. A long-term benefit can have considerable economic importance and uncertain relevance to a customer who must exit early. A defensible value-for-money judgment accordingly requires documented scenario results, segment-specific evidence, comparable cost and benefit definitions, and a governance process capable of investigating and correcting adverse outcomes.

References

  • Bauer, D., Kling, A., & Russ, J. (2008). A universal pricing framework for guaranteed minimum benefits in variable annuities. ASTIN Bulletin: The Journal of the IAA, 38(2), 621–651. DOI: 10.2143/AST.38.2.2033356. Source

  • Egan, M., Ge, S., & Tang, J. (2022). Conflicting interests and the effect of fiduciary duty: Evidence from variable annuities. The Review of Financial Studies, 35(12), 5334–5386. DOI: 10.1093/rfs/hhac047. Source

  • European Commission. (2017). Commission Delegated Regulation (EU) 2017/2358 of 21 September 2017 supplementing Directive (EU) 2016/97 with regard to product oversight and governance requirements for insurance undertakings and insurance distributors. OJ L 341, 20 December 2017, 1–7. Source

  • European Commission. (2017). Commission Delegated Regulation (EU) 2017/653 of 8 March 2017 supplementing Regulation (EU) No 1286/2014 with regulatory technical standards for key information documents for packaged retail and insurance-based investment products. OJ L 100, 12 April 2017, 1–52. Consolidated text, 1 January 2023. Source

  • European Insurance and Occupational Pensions Authority. (2021, November 30). Supervisory statement on assessment of value for money of unit-linked insurance products under product oversight and governance. Source

  • European Insurance and Occupational Pensions Authority. (2022, October 31). Methodology to assess value for money in the unit-linked market. Source

  • European Insurance and Occupational Pensions Authority. (2026, April 1). Costs and past performance report 2026. Source

  • European Insurance and Occupational Pensions Authority. (2026, April 1). EIOPA report shows overall positive net returns, although the wide variation amongst products underscores the importance of target markets. Source

  • European Insurance and Occupational Pensions Authority. (2026, July 6). Revised Methodology on Value for Money Benchmarks. EIOPA-BoS-26-304. Source

  • European Parliament and Council. (2016). Directive (EU) 2016/97 of 20 January 2016 on insurance distribution (recast). OJ L 26, 2 February 2016, 19–59. Consolidated text, 9 January 2024. Source

  • European Parliament. (2026). Retail investor protection rules. Legislative Observatory, procedure 2023/0167(COD). Accessed November 19, 2026. Source

  • Financial Conduct Authority. (2023, May 10; updated 2025, December 3). Consumer Duty: Findings from our review of fair value frameworks. Source

  • National Association of Insurance Commissioners. (n.d.). Annuity Suitability and Best Interest Standard. Insurance Topics. Accessed November 19, 2026. Source

  • U.S. Securities and Exchange Commission. (n.d.). Variable Annuities. Investor.gov. Accessed November 19, 2026. Source